In patients with primary UM, while circulating anti-tumor CD3–CD56dim NK cells and CD8+ and double-negative CD3+CD56+ NK-T cells decrease, pro-tumoral ICOS+CD4+FoxP3+ Treg cells increase (63), further supporting a role for Treg in tumor progression. The gene discussed is CD4; the disease is neoplasm.